Analogs of gastric inhibitory polypeptide and their use for treatment of diabetes
US6921748B1 · kind B1 · utility
12Cited by
0References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 29, 2000 |
| Grant date | Jul 26, 2005 |
| Priority date | — |
| Expiry date | Mar 29, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides peptides which stimulate the release of insulin. The peptides, based on GIP 1-42, include substitutions and/or modifications which enhance and influence secretion and/or have enhanced resistance to degradation. The invention also provides a process of N terminally modifying GIP and the use of the peptide analogues for treatment of diabetes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.